Nkarta Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.67

-0.08 (-2.91%)

As of Sep 28, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +520.6% upside

Low Target $14.06

Average Target $16.57

High Target $23.26

Current Price $2.67

Current
$2.67

Target
$16.57

$14.06 $16.57 avg $23.26

Scenario Analysis

Bear Case

$14.06

426.6%

Low target

Base Case

$16.57

+520.6%

Avg target

Bull Case

$23.26

+771.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$3.72

-28.2% from high

52-Week Low

$1.70

+57.1% from low

Target vs 52W High

$16.57

+345.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-26.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.2%